Cell : The Lancet - Translational Medicine

Speaker

Daniel R. KURITZKES, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, USA

Daniel R. KURITZKESDaniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School. He completed his clinical and research training in internal medicine and infectious disease at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital.

Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection. He has chaired several multicenter studies of HIV therapy and is a member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy. He has served on numerous NIH committees and editorial boards, and previously served as Chair of the HIV Medicine Association Board of Directors. He currently serves as Principal Investigator and Chair of the AIDS Clinical Trials Group, and as an Associate Editor of the Journal of Infectious Diseases.  His research interests focus on antiretroviral therapy, drug resistance and HIV eradication.

« Go Back

Organized by

Elsevier
Journal - The Lancet
Journal - Cell
Elsevier

Partners

Timothy Ray Brown
World AIDS Institute